In the last 12 months, insiders at Tempest Therapeutics made open-market purchases of $500,001 (231.48K shares) and sold no shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Matthew Angel | Ceo And President | 0 | 231,482 | 231,482 | 54.4% | 25 Mar, 2026 |
| 2 | Thomas Woiwode | Director, TenPercentOwner | 0 | 162,966 | 162,966 | 38.3% | 03 May, 2022 |
| 3 | Venture Capital Vi, L.P. Versant | TenPercentOwner | 16,149 | 0 | 16,149 | 3.8% | 12 Aug, 2024 |
| 4 | Thomas W. Dubensky | President | 8,718 | 0 | 8,718 | 2.0% | 11 Jan, 2022 |
| 5 | Stephen R Brady | President And Ceo | 3,567 | 0 | 3,567 | 0.8% | 08 Jul, 2024 |
| 6 | Justin Trojanowski | Corporate Controller | 1,705 | 0 | 1,705 | 0.4% | 02 Jul, 2024 |
| 7 | Samuel Whiting | Chief Medical Officer | 736 | 0 | 736 | 0.2% | 03 Jul, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 22 Sep, 2026 | Nancy Freda Smith | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 04 Jun, 2026 | John D. Yee | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 04 Jun, 2026 | William Drake Richey | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 31 Mar, 2026 | Justin Trojanowski | Corporate Controller | Acquired A | 22,000 | $0.00 | $0 | 22,000 | Direct |
| 31 Mar, 2026 | Nicholas Maestas | Chief Financial Officer | Acquired A | 140,000 | $0.00 | $0 | 140,000 | Direct |
| 24 Mar, 2026 | Matthew Angel | Ceo And President | Acquired P | 231,482 | $2.16 | $500.00K | 231,482 | Indirect |
| 04 Feb, 2026 | Matthew Angel | Ceo And President | Acquired A | 269,621 | $0.00 | $0 | 269,621 | Direct |
| 27 Jan, 2026 | Christine A Pellizzari | Director | Acquired A | 1,230 | $0.00 | $0 | 1,230 | Direct |
| 27 Jan, 2026 | Ronit Simantov | Director | Acquired A | 1,230 | $0.00 | $0 | 1,230 | Direct |
| 27 Jan, 2026 | Michael Raab | Director | Acquired A | 1,230 | $0.00 | $0 | 1,230 | Direct |
| 27 Jan, 2026 | Geoffrey Nichol | Director | Acquired A | 1,230 | $0.00 | $0 | 1,230 | Direct |
| 02 Jan, 2025 | Stephen R Brady | President And Ceo | Acquired A | 550,000 | $0.00 | $0 | 42,306 | Direct |
| 02 Jan, 2025 | Justin Trojanowski | Corporate Controller | Acquired A | 30,000 | $0.00 | $0 | 2,308 | Direct |
| 02 Jan, 2025 | Nicholas Maestas | Chief Financial Officer | Acquired A | 200,000 | $0.00 | $0 | 15,384 | Direct |
| 02 Jan, 2025 | Samuel Whiting | Chief Medical Officer | Acquired A | 270,000 | $0.00 | $0 | 20,768 | Direct |
| 08 Aug, 2024 | Venture Capital Vi, L.P. Versant | TenPercentOwner | Disposed S | 400,000 | $17.55 | $7.02Mn | 45,994 | Direct |
| 12 Aug, 2024 | Venture Capital Vi, L.P. Versant | TenPercentOwner | Disposed S | 387,999 | $14.31 | $5.55Mn | 16,149 | Direct |
| 03 Jul, 2024 | Stephen R Brady | President And Ceo | Acquired P | 35,000 | $27.43 | $960.09K | 3,567 | Direct |
| 02 Jul, 2024 | Samuel Whiting | Chief Medical Officer | Acquired P | 4,672 | $27.69 | $129.37K | 736 | Direct |
| 28 Jun, 2024 | Justin Trojanowski | Corporate Controller | Acquired P | 7,500 | $28.08 | $210.61K | 1,705 | Direct |